Previous studies have shown that SNPs within miRNA binding sites of genes involved in tumor growth and progression, such as ERBB4, EGFR, STAT3, ERBB2, JAK1, SOX6, SGSM3, and SET8, can influence the risk and outcome of HCC [150–157] (Table 3). This evidence concerns the gene EGFR and hepatocellular carcinoma.